Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 8,700
- Avg volume
- 1,784
- Day's range
- $0.12 – $0.13
- Shares out
- —
- Stochastic %K
- 3%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Aquiva Group Inc., through its subsidiary, Aquiva Medical Inc., engages in the commercialization of AquiForm, a proprietary, versatile topical materials platform based on its novel Hydrogel with inter-Penetration Network Anchor (HiPNA) vehicle for consumer health, wellness, and cosmetics; medical device; and therapeutics and transdermal drug-delivery systems. The company was formerly known as BHPA, INC. and changed i...
Show more
Aquiva Group Inc., through its subsidiary, Aquiva Medical Inc., engages in the commercialization of AquiForm, a proprietary, versatile topical materials platform based on its novel Hydrogel with inter-Penetration Network Anchor (HiPNA) vehicle for consumer health, wellness, and cosmetics; medical device; and therapeutics and transdermal drug-delivery systems. The company was formerly known as BHPA, INC. and changed its name to Aquiva Group Inc. in May 2025. The company was incorporated in 2005 and is based in Bethesda, Maryland.
- Industry
- Software - Application
- Sector
- Technology
- Phone
- 202 536 5191
- Website
- https://www.aquivamedical.com
- Address
- #3 Bethesda Metro Cente, Suite 700, Bethesda, United States
Latest news
No headlines yet.
